24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
Go back to 24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference| Abbott Laboratories (NYSE: ABT) | Delayed: 111.25 -0.02 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $111.27 | 52 Week High | $46.38 | |||
| Open | $111.49 | 52 Week Low | $36.00 | |||
| Day High | $111.97 | P/E | 74.17 | |||
| Day Low | $110.79 | EPS | $1.50 | |||
| Volume | 5,575,610 | |||||
| SurModics, Inc. (NASDAQ: SRDX) | Delayed: 42.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.98 | 52 Week High | $30.75 | |||
| Open | $42.98 | 52 Week Low | $17.45 | |||
| Day High | $42.98 | P/E | 44.31 | |||
| Day Low | $42.98 | EPS | $0.97 | |||
| Volume | 5,905 | |||||
